Thermo Fisher Scientific (TMO) Change in Cash (2009 - 2026)

Thermo Fisher Scientific has disclosed Change in Cash across 18 years of filings, most recently posting -$6.6 billion for Q1 2026.

• Quarterly Change in Cash fell 5099.24% year-over-year to -$6.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$892.0 million (up 33.78% YoY) and the FY2025 annual result came in at $5.8 billion, up 243.92% from the prior year.
• Change in Cash slipped to -$6.6 billion in Q1 2026, from $7.9 billion in the prior quarter.
• Over five years, Change in Cash peaked at $7.9 billion in Q4 2025 and troughed at -$6.6 billion in Q1 2026.
• A 5-year average of -$71.2 million and a median of -$347.0 million in 2023 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2025 — Change in Cash jumped 1348.89% — and 2026, when it slumped 5099.24%.
• Tracing TMO's Change in Cash over 5 years: stood at $5.6 billion in 2022, then sank by 65.57% to $1.9 billion in 2023, then tumbled by 132.66% to -$630.0 million in 2024, then soared by 1348.89% to $7.9 billion in 2025, then slumped by 183.87% to -$6.6 billion in 2026.
• Business Quant data shows TMO's Change in Cash at -$6.6 billion in Q1 2026, $7.9 billion in Q4 2025, and -$2.6 billion in Q3 2025.